Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Fichtenbaum

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
AIDS (London, England)|June 6, 2000
Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295C J Fichtenbaum, R Zackin, N Rajicic, et al.
AIDS Research and Human Retroviruses|February 16, 2008
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patientsP A Velilla, M T Shata, C S Lages, et al.
The Journal of Infectious Diseases|August 1, 1995
Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous systemJ R Arribas, D B Clifford, C J Fichtenbaum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin BC J Fichtenbaum, M German, W C Dunagan, et al.
Journal of Clinical Microbiology|June 1, 1995
Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphomaJ R Arribas, D B Clifford, C J Fichtenbaum, et al.
Epidemiology and Infection|February 17, 2017
Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysisM A Huaman, R J Kryscio, C J Fichtenbaum, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 1, 1997
The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDSA W Wu, D L Jacobson, R A Berzon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2000
Refractory mucosal candidiasis in advanced human immunodeficiency virus infectionC J Fichtenbaum, S Koletar, C Yiannoutsos, et al.
Annals of Internal Medicine|October 7, 2014
Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1J L Lennox, R J Landovitz, H J Ribaudo, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
AIDS (London, England)|June 6, 2000
Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295C J Fichtenbaum, R Zackin, N Rajicic, et al.
AIDS Research and Human Retroviruses|February 16, 2008
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patientsP A Velilla, M T Shata, C S Lages, et al.
The Journal of Infectious Diseases|August 1, 1995
Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous systemJ R Arribas, D B Clifford, C J Fichtenbaum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin BC J Fichtenbaum, M German, W C Dunagan, et al.
Journal of Clinical Microbiology|June 1, 1995
Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphomaJ R Arribas, D B Clifford, C J Fichtenbaum, et al.
Epidemiology and Infection|February 17, 2017
Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysisM A Huaman, R J Kryscio, C J Fichtenbaum, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 1, 1997
The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDSA W Wu, D L Jacobson, R A Berzon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2000
Refractory mucosal candidiasis in advanced human immunodeficiency virus infectionC J Fichtenbaum, S Koletar, C Yiannoutsos, et al.
Annals of Internal Medicine|October 7, 2014
Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1J L Lennox, R J Landovitz, H J Ribaudo, et al.
Pageof 3